Prefilled Syringes: Global Markets

Report Code: HLC223B

Publish Date: Jun 2024

Publisher: BCC Publishing

Category: Health Maintenance

Download Report Overview

Single User License: $4650

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for prefilled syringes is expected to grow from $14.5 billion in 2024 and is projected to reach $22.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2024 to 2029.

Report Includes

  • 55 data tables and 29 additional tables
  • An updated review of the global markets for prefilled syringes
  • Analysis of global market trends, featuring historical revenue data for 2021-2023, estimated figures for 2024, forecasts for 2029, and projections of compound annual growth rates (CAGRs) through 2029
  • Evaluation of the current market’s size and revenue growth prospects specific to prefilled syringes, along with a market share analysis by material, application, design, therapeutics, and geographic region
  • In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market
  • Assessment of major market drivers and opportunities estimating current and future demand for prefilled syringes, and key enabling technologies, and COVID-19 impact on the prefilled syringes
  • Discussion of key technology developments, latest trends, and other influential factors
  • Coverage of upcoming market opportunities and areas of focus to forecast this market into various segments and sub-segments
  • Insight into recent industry structure, current competitive scenario, R&D activities, and regulatory and legislative issues currently focused on medical industry
  • An analysis of key patents
  • Profiles of the leading players, including Becton Dickinson and Co., Baxter, Gerresheimer AG, Schott Pharma AG & Co. KGaA, and West Pharmaceuticals

Report Scope

The current report provides detailed information on the market for prefilled syringes. This report analyzes the market trends of prefilled syringes with data from 2023, estimates from 2024, projections of compound annual growth rates (CAGRs) through 2029 (forecast period 2024 to 2029) and regional markets for prefilled syringes. This report will highlight prefilled syringes’ current and future market potential and a detailed competitive environment analysis. The recent report will cover regulatory scenarios, drivers, restraints and opportunities. The report also covers market projections for 2029 and the market share for key players.

The market scope in this report is segmented into material, type, design and therapeutics. Based on materials, the report covers glass-based and polymer-based prefilled syringes. The market breakdown by type includes conventional and safety-prefilled syringes. The market is segmented based on design into single-chamber prefilled syringes, dual-chamber and customized prefilled syringes. The report reviews small molecules, heparins, vaccines and all other biologics in the therapeutics segment. It reviews the main prefilled syringe applications, which include arthritis, diabetes, cancer and others.

The market has been segmented into significant geographies, including North America, Europe, Asia-Pacific and other world regions. The regional segment will cover a detailed analysis of major countries, including the U.S., Germany, the U.K., France, Japan, China and India. The market value is estimated for 2023, with forecasts for 2024 and 2029.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2024-2029
Base year market size $13.3 Billion
Market size forecast $22.8 Billion
Growth rate CAGR of 9.5% for the forecast period of 2024-2029
Units considered $ Millions
Segments covered Material, Design, Therapeutics, Application, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Countries covered U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China, India, Brazil
Key Market Drivers
  • Rising number of chronic diseases.
  • Increasing use of prefilled syringes.
  • Technologically advanced prefilled syringes.
  • Benefits associated with prefilled syringes.
  • Increasing demand for home-based healthcare.
  • Improved safety standards.
  • Increasing demand for self-injection devices.
  • Growing elderly population worldwide.
Companies studied
ARTE CORP.BAXTER
BDF. HOFFMANN-LA ROCHE LTD.
GERRESHEIMER AGHASELMEIER
NIPROSHL MEDICAL AG
STEVANATO GROUPYPSOMED
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The global prefilled syringes market was valued at $13.3 billion in 2023 and will reach $22.8 billion by 2029.
The growth of the global market is attributed to factors such as advantages of prefilled syringes over traditional vials include ease of use, lack of dosing errors, and the ability of patients to self-administer.
The market scope in this report is segmented into material, type, design, and therapeutics. Based on materials, the report covers glass-based and polymer-based prefilled syringes. The market breakdown by type includes conventional and safety-prefilled syringes. The market is segmented based on design into single-chamber prefilled syringes, dual-chamber, and customized prefilled syringes. The report reviews small molecules, heparins, vaccines, and all other biologics in the therapeutics segment. The report reviews the main prefilled syringe applications, which include arthritis, diabetes, cancer, and others.
Glass Prefilled syringes will dominate the market for prefilled syringes.
The North American prefilled syringes market was valued at $7.0 billion in 2023 and estimated to be $12.0 billion in 2029, growing at a CAGR of 9.6% during the forecast period.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Melissa Dueck brings more than 25 years of health industry experience to the consulting analyst role with expertise in pharmaceuticals, medical technologies, and hospital operations. Ms. Dueck holds an MBA in Health Care Management, an MPH in Global Health, and is a pending doctoral candidate. She has authored several industry-specific documents and is a well-respected, trusted contributor to the market intelligence community. Her writings are published in magazines, newspapers, and professional journals. She is also an experienced custom market research writer who has worked with a large variety of clients in many fields who require innumerable variations to research documents. Ms. Dueck serves the health and medical community through emergency room medical training, healthcare information system coordination, program implementation and evaluations, and strategic business oversight planning.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Prefilled Syringes: Global Markets90Free
Chapter- 1: Executive Summary4Free
Chapter- 2: Market Overview3Free
Chapter- 3: Market Dynamics14Free
Chapter- 4: Regulatory and Reimbursement Landscape6Free
Chapter- 5: Product Pipeline for Prefilled Syringes1Free
Chapter- 6: Market Segmentation Analysis28Free
Chapter- 7: Competitive Intelligence1Free
Chapter- 8: Sustainability in Prefilled Syringes: An ESG Perspective4Free
Chapter- 9: Appendix: Global Prefilled Syringes Market29Free
Published - Mar-2019| Analyst - BCC Publishing| Code - HLC223A

Report Highlights

The global market for prefilled syringes should grow from $4.7 billion in 2018 to $7.3 billion by 2023 at a compound annual growth rate (CAGR) of 9.3% for the period of 2018-2023.

Report Includes

  • 24 data tables and 21 additional tables
  • Industry analysis of the global markets for prefilled syringes within the healthcare sector
  • Analyses of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Regional dynamics of the prefilled syringes market covering North America, Europe, Asia-Pacific and other emerging economies
  • A look at key resins used to make these syringes, and new products and technologies related to these devices
  • Examination of the market dynamics, including growth inhibiting drivers, restraints, and opportunities
  • General assessment of key patents approved for prefilled syringes in the U.S., Europe and APAC region
  • Profiles of major manufacturers and suppliers of prefilled syringes, including Aptar Pharma, Baxter International Inc., Biocorp, Medtronic and West Pharmaceutical Services, Inc.

Related Reports

Global Markets for Drug-Device Combinations

Published - Jul 2024 | Publisher - BCC Publishing | Code - PHM045F

The global market for drug-device combinations is expected to grow from $129.4 billion in 2024 and is projected to reach $199.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2024 to 2029.

Global Markets and Technologies for Advanced Drug Delivery Systems

Published - Mar 2024 | Publisher - BCC Publishing | Code - PHM006N

The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.

Global Markets for Insulin Drug and Delivery Technologies

Published - Sep 2022 | Publisher - BCC Publishing | Code - HLC149B

The global market for insulin drug and delivery technologies is estimated to increase from $55.8 billion in 2022 to reach $88.9 billion by 2027, at a compound annual growth rate (CAGR) of 9.8% from 2022 through 2027.

Smart Medical Devices: Global Markets

Published - Jul 2022 | Publisher - BCC Publishing | Code - MDS066A

The global market for smart medical devices reached $56.4 billion in 2021 and should reach more than $122.8 billion in 2026, with a compound annual growth rate (CAGR) of 16.8% during the forecast period of 2021-2026.

Recent Reports

Conventional and Alternative Pain Treatment Markets

Published - Nov 2024 | Publisher - Partha Sarathi Das | Code - HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Prefilled Syringes: Global Markets
Sample Report